Background: Immune reconstitution inflammatory syndrome (IRIS) in AIDS patients initiating anti-retroviral therapy (ART) is driven by immune dysregulation mechanisms. Biomarkers are needed to identify patients at risk.
Methods: Two hundred sixty-seven ART naïve patients with CD4 <100 cells/uL were enrolled in a multicenter, randomized placebo controlled ART initiation trial in South Africa and Mexico to test whether maraviroc added to an ART regimen could prevent IRIS. Participants were followed longitudinally for 6 months and IRIS events were reviewed prospectively based on the ACTG criteria. Pre-ART cryo-preserved plasma was used to measure cytokines (IFNγ, TNFα, IL-1β, IL-6, IL-10, IL-17), markers of myeloid cell activation (sCD14, sCD163), coagulation (D-dimer), CRP and vitamin D. Biomarkers with skewed distributions were log transformed prior to comparisons. Biomarkers in patients who developed IRIS were compared to the remaining cohort that did not develop IRIS after 6 months of follow-up. Biomarkers were then individually tested while adjusting for significant covariates selected through forward stepwise selection.
Results: Participants had a median age of 36, median CD4 count of 43 cells/µL, and median HIV-RNA 5.4 log10 copies/mL. Sixty-two participants developed IRIS and of these 21% were TB-IRIS. Patients who developed IRIS were more likely to be male (79% vs. 62%), with a prior AIDS–defining illnesses (79% vs. 54%), and a lower median hemoglobin (11.9 vs. 12.3 g/dL). Prior to ART, lower vitamin D, higher D-dimer, IFNy, and sCD14 were independently associated with risk for IRIS in a multivariate analysis. A subgroup analysis of TB-IRIS cases (N=21) vs. patients without TB-IRIS was performed and revealed baseline levels of IFNγ, CRP, and sCD14 were independent predictors of TB-IRIS risk, while vitamin D levels were not associated with TB-IRIS in univariate or multivariate analyses.
Conclusions: Biomarkers of T cell and monocyte activation (IFNγ, sCD14), coagulation (D-dimer) and low vitamin D prior to ART initiation are independently associated with IRIS. Further evaluation of these biomarkers as possible clinical prediction tools or targets of intervention for IRIS prevention is warranted.
Data represent medians with interquartile ranges. * Denotes significance after multivariate adjustment for gender, hemoglobin, and prior AIDS-defining illness.